Published On: January 14, 2025229 words1.4 min readCategories: ArticleTags:

Share this story:

As you consider what the second term of President Trump means for health and pharmacy policy, the following likely come to mind:

  • RFK, Jr., Dr. Oz, and Other Trump Nominees to Health Agencies
  • Vaccine Policy in the New Administration
  • PBM Reform
  • DOGE, Regulatory Reform and the End of the 40-Year “Chevron Deference”
  • Food is Medicine in the New Administration
  • Tariffs, Economic Growth and Inflation
  • The 2024 Elections: “Mandates and Margins” in the 119th Congress
  • Who’s on Deck for President in 2028
  • And Much More.

Please join us for a discussion of these topics at 10:00 am Eastern on Inauguration Day, January 20, 2025. The discussion will be shown on Zoom. Register now!

Participants include:

  • Steve Anderson, President and CEO, National Association of Chain Drug Stores
  • Keith Nahigian, President, Nahigian Strategies
  • Jack Kalavritinos, Founder and Principal, JK Strategies.

They have more than eight decades of combined policy and political knowledge and expertise from holding senior positions in Presidential and Congressional election campaigns, serving in senior staff positions in Congress, serving in the White House, and leading federal health agencies in Washington, D.C

This event will be shown at the NACDS Regional Chain Conference on Monday, January 20, 2025, and we want you to be able to benefit from it if you’re not attending the conference.

Please share this event with your teams, colleagues, association members, collaborators, pharmacists and employees, and student pharmacists.